Your browser doesn't support javascript.
loading
Impact of perioperative fluid administration on early outcomes after pancreatoduodenectomy: A meta-analysis.
Huang, Yeqian; Chua, Terence C; Gill, Anthony J; Samra, Jaswinder S.
Affiliation
  • Huang Y; Department of Gastrointestinal Surgery, Royal North Shore Hospital, St Leonards, NSW, Australia; Discipline of Surgery, University of Sydney, Sydney, NSW, Australia.
  • Chua TC; Department of Gastrointestinal Surgery, Royal North Shore Hospital, St Leonards, NSW, Australia; Discipline of Surgery, University of Sydney, Sydney, NSW, Australia. Electronic address: terence.c.chua@gmail.com.
  • Gill AJ; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia; University of Sydney, Sydney, NSW, Australia; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia.
  • Samra JS; Department of Gastrointestinal Surgery, Royal North Shore Hospital, St Leonards, NSW, Australia; Discipline of Surgery, University of Sydney, Sydney, NSW, Australia; Macquarie University Hospital, Macquarie University, NSW, Australia.
Pancreatology ; 17(3): 334-341, 2017.
Article in En | MEDLINE | ID: mdl-28285959
ABSTRACT

BACKGROUND:

Pancreatoduodenectomy (PD) remains a technically challenging surgical procedure with morbidity rates ranging between 30 and 50%. It is suggested that the liberal use of fluids is associated with a poor perioperative outcome. This review examines the impact of fluid administration on outcomes after PD.

METHODS:

A literature search was conducted using the MEDLINE, EMBASE and PubMed database (June 1966-June 2016). Studies identified were appraised with standard selection criteria. Data points were extracted and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).

RESULTS:

Eleven studies, seven retrospective trials and four randomized control trials comprising 2842 patients were included. Seven studies were meta-analyzed. There was no difference in length of hospital stay (P = 0.25), pancreas specific complications (P = 0.20), pulmonary (P = 0.58), cardiovascular (P = 0.75), gastrointestinal (P = 0.49), hepatobiliary (P = 0.53), urogenital (P = 0.42), wound complication (P = 0.79), reoperation rate (P = 0.69), overall morbidity (P = 0.18), major morbidity (P = 0.91), 30-day mortality (P = 0.07) and 90-day mortality (P = 0.58) in low or high fluid groups.

CONCLUSION:

The current available data fails to demonstrate an association between the amount of perioperative intravenous fluid administration and postoperative complications in patients undergoing PD.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pancreaticoduodenectomy / Perioperative Care / Fluid Therapy Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pancreaticoduodenectomy / Perioperative Care / Fluid Therapy Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Year: 2017 Type: Article